Abstract:Li-Yu Chen, 1 Chen-Yu Wang, 1, 2 Chi-Ying Lin, 3 Ming-Jui Tsai, 3 Wei-Hsun Shen, 1 Pei-Jhih Li, 1 Lin-Chu Liao, 1 Chih-Fen Huang, 4, 5 Chien-Chih Wu 4 1 Department of Pharmacy, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan; 2 National Center for Geriatrics and Welfare Research, National Health Research Institutes, Yunlin, Taiwan; 3 Department of Internal Medicine, National Taiwan University Hospital Yunlin Branch, Yunlin, Taiwan; 4 Department of Pharmacy, National Taiwan University Hospital, Taipei, Taiwan; 5 School of Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan Correspondence: Chien-Chih Wu, Department of Pharmacy, National Taiwan University Hospital, 7 Chung Shan S. Road, Taipei, Taiwan, Email ; Background: In the field of postoperative care, infections caused by Gram-positive bacteria pose a major clinical challenge. Vancomycin is a key therapeutic agent whose efficacy is greatly influenced by renal function, particularly by augmented renal clearance (ARC). The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) estimated glomerular filtration rate (eGFR) is an easy and commonly used method to predict ARC; however, it is not well studied to determine vancomycin dose. In this study, we examined the effectiveness of the CKD-EPI equation in determining ARC and optimizing the dose of vancomycin for surgical ward patients. Methodology: A retrospective observational study was conducted to examine 158 surgical ward patients receiving vancomycin. Data on demographics, medical history, and vancomycin dosing were collected. Renal function was evaluated using the CKD-EPI equation, with ARC defined as eGFR ≥ 96.5 mL/min/1.73 m 2 . Vancomycin pharmacokinetics were calculated using the ClinCalc tool. Results: ARC was in 54% of the patients. Compared with patients without ARC, those with ARC were younger and had lower serum creatinine levels. They also required higher vancomycin doses but had lower trough concentrations and 24-hour area-under-the-curve values. A significant correlation was observed between eGFR and vancomycin clearance, with eGFR > 96.5 mL/min/1.73 m 2 necessitating higher vancomycin doses (> 45 mg/kg/day) to achieve the desired area under the curve to minimum inhibitory concentration ratio. Conclusion: For surgical ward patients with CKD-EPI eGFR ≥ 96.5 mL/min/1.73 m 2 , a vancomycin dosage of > 45 mg/kg/day may be recommended to reach effective therapeutic levels. Overall, this study emphasizes the importance of tailoring vancomycin therapy depending on renal function to ensure efficacy and mitigate the risk of antimicrobial resistance in surgical ward patients. Keywords: augmented renal clearance, vancomycin, surgery Postoperative infection is a common complication of surgery, which may prolong hospitalization and affect prognosis. 1 Gram-positive bacteria are often involved in postoperative infections. 2 With the emergence of drug-resistant strains, vancomycin plays a key role in combating infections caused by Gram-positive bacteria, particularly by Staphylococcus aureus . 3–5 The pharmacokinetic/pharmacodynamic (PK/PD) target of vancomycin is defined as the ratio between the area under the curve (AUC) and the minimum inhibitory concentration (MIC), with an optimal target range of 400 to 600 to ensure efficacy and reduce nephrotoxicity. 4 Optimizing the PK/PD target of antibiotics can improve clinical outcomes. 6 AUC/MIC monitoring is primarily recommended for serious methicillin-resistant Staphylococcus aureus (MRSA) infections, such as bacteremia, infective endocarditis, and pneumonia, due to its stronger correlation with clinical outcomes. 4 It is also preferred for patients at high risk of nephrotoxicity, including critically ill patients, patients with unstable renal function, and those on prolonged vancomycin therapy. 4 Trough-only monitoring is no longer recommended due to the higher likelihood of achieving an AUC/MIC >400 with trough concentrations between 10 and 15 mg/L, and the increased risk of nephrotoxicity when trough concentrations exceed 15 mg/L. 7,8 Moreover, numerous studies have demonstrated that AUC-guided monitoring reduces the risk of nephrotoxicity compared to trough-only monitoring. 9 Currently, only for patients undergoing hemodialysis, pre-dialysis concentrations with a target range of 15–20 mg/L are used instead of targeting AUC/MIC. 10 Therefore, identifying the factors affecting the PK/PD target and promptly adjusti -Abstract Truncated-

Characterizing Day 1 Area Under the Curve Following Vancomycin Loading Dose Administration in Adult Hospitalized Patients Using Non-Trapezoidal Linear Pharmacokinetic Equations: A Retrospective Observational Study

Predicting the Area under the Plasma Concentration-Time Curve (AUC) for First Dose Vancomycin Using First-Order Pharmacokinetic Equations

Impact of the First Twenty-Four-Hour Area Under the Concentration-Time Curve/Minimum Inhibitory Concentration of Vancomycin on Treatment Outcomes in Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia

Population Pharmacokinetics and Pharmacodynamics of Vancomycin in Pediatric Patients With Various Degrees of Renal Function

A higher area under the concentration-time curve/minimum inhibitory concentration target as a potential prognostic factor for vancomycin treatment of methicillin-resistant Staphylococcus aureus meningitis: A case report

Evaluation of Vancomycin Dose Needed to Achieve 24-Hour Area Under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio Greater Than or Equal to 400 Using Pharmacometric Approaches in Pediatric Intensive Care Patients

Development and Assessment of Vancomycin Dosing Utilizing AUC/MIC Protocol in Patients With End-Stage Renal Disease (ESRD) on Intermittent Hemodialysis (IHD)

Population Pharmacokinetics and Pharmacodynamics Analysis of Vancomycin in Patients with Severe Lower Respiratory Tract Gram-Positive Infections

Predictive Value of Vancomycin AUC24/MIC Ratio for 30-day Mortality in Patients with Severe or Complicated Methicillin-Resistant Staphylococcus aureus Infections: A Multicenter Retrospective Study

Implementation of vancomycin AUC/MIC dosing vs traditional trough dosing and incidence of acute kidney injury at a rural community hospital

Vancomycin AUC0-24 estimation using first-order pharmacokinetic methods in pediatric patients

Automated calculation and reporting of vancomycin area under the concentration-time curve: a simplified single-trough concentration-based equation approach

Pharmacokinetics of Vancomycin in Healthy Korean Volunteers and Monte Carlo Simulations to Explore Optimal Dosage Regimens in Patients with Normal Renal Function

Implementing AUC Monitoring in a Pharmacist-Managed Vancomycin Dosing Protocol: A Retrospective Cohort Study

Vancomycin area under the curve/minimum inhibitory concentration and trough level concordance–evaluation on an urban health unit

Interinstitutional Comparison of Vancomycin Area Under the Concentration-Time Curve Estimation in Korea: Need for Standardized Operational Protocols for Therapeutic Drug Monitoring Consultation

Vancomycin loading dose is associated with increased early clinical response without attainment of initial target trough concentration at a steady state in patients with methicillin‐resistant Staphylococcus aureus infections

Simulation of Vancomycin Exposure Using Trough and Peak Levels Achieves the Target Area under the Steady-State Concentration-Time Curve in ICU Patients

Relationship between nephrotoxicity and area under the concentration–time curve of vancomycin in critically ill patients: a multicenter retrospective study

Earlier Targeted Vancomycin Troughs Concentration with Loading Dose: A Retrospective Study

Optimize Vancomycin Dose in Surgical Ward Patients with Augmented Renal Clearance Determined by Chronic Kidney Disease Epidemiology Collaboration Equation